The Supreme Court has indefinitely extended a freeze on new restrictions for the abortion pill mifepristone, allowing continued mail-order prescribing and telehealth access. This decision provides temporary legal certainty for healthcare providers and pharmacies while a broader legal challenge to the drug's accessibility proceeds. The case, which originated from a lawsuit filed by Louisiana, questions the Biden administration's rules that expanded access to mifepristone, including its availability via mail and telehealth. AI
Summary written by gemini-2.5-flash-lite from 3 sources. How we write summaries →
RANK_REASON Supreme Court ruling on drug access with significant policy implications. [lever_c_demoted from significant: ic=3 ai=0.1]
